ASRS
AKBA icon

Arizona State Retirement System’s Akebia Therapeutics AKBA Stock Holding History

Arizona State Retirement System’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,845
Closed -$111K – 2052
2025
Q4 		$111K Sell
68,845
-8,618
-11% -$18K ﹤0.01% 2018
2025
Q3 		$211K Buy
+77,463
New +$258K ﹤0.01% 1929
2022
Q2 		– Sell
-44,930
Closed -$32K – 2247
2022
Q1 		$32K Buy
44,930
+303
+0.7% +$648 ﹤0.01% 2228
2021
Q4 		$101K Buy
44,627
+3,194
+8% +$8.71K ﹤0.01% 2215
2021
Q3 		$119K Buy
41,433
+1,793
+5% +$5.12K ﹤0.01% 2165
2021
Q2 		$150K Sell
39,640
-332
-0.8% -$1.12K ﹤0.01% 2175
2021
Q1 		$135K Buy
39,972
+487
+1% +$1.75K ﹤0.01% 2098
2020
Q4 		$111K Sell
39,485
-1,003
-2% -$2.93K ﹤0.01% 2061
2020
Q3 		$102K Buy
40,488
+14,984
+59% +$131K ﹤0.01% 1943
2020
Q2 		$346K Buy
25,504
+7,354
+41% +$76.1K ﹤0.01% 1334
2020
Q1 		$138K Buy
+18,150
New +$141K ﹤0.01% 1588

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Arizona State Retirement System's AKBA Position: Q1 2026 in Review

Arizona State Retirement System sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 68,845 shares — an estimated $111K sold.

Arizona State Retirement System first reported a position in AKBA in Q1 2020 and held it in 11 quarters. The position peaked at $346K in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Arizona State Retirement System reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Arizona State Retirement System sold 68,845 Akebia Therapeutics shares in Q1 2026, an estimated $111K.
  • Arizona State Retirement System first reported a position in Akebia Therapeutics in Q1 2020 and held it in 11 quarters.
  • Arizona State Retirement System's Akebia Therapeutics position peaked at $346K in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.